Importantly, we demonstrated the combinatorial treatment with anti-PD-1 and anti-Dectin-1 antibody elicit a synergistic effect in promoting CD8+ T-cell proliferation and tumour cell apoptosis, suggesting that Dectin-1+ TAMs were expected to be immunotherapeutic targets and enhanced the anti-tumour effects of ICIs. Here, CD8A is linked to neoplasm.